SCOTT HENNIGAR: Open Payments
NPI 1306213483 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,915 in 80 payments from 20 companies in 2025. Trend: 2023 $900 · 2024 $1,540 · 2025 $1,915
Food & beverage: $1,896Education: $19
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $414 |
| Vifor Pharma, Inc. | 8 | $186 |
| OPKO Pharmaceuticals, LLC | 13 | $185 |
| Calliditas Therapeutics US Inc. | 6 | $162 |
| Inspire Medical Systems, Inc. | 1 | $144 |
| Alexion Pharmaceuticals, Inc. | 1 | $118 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $114 |
| Otsuka America Pharmaceutical, Inc. | 5 | $95 |
| Fresenius USA Marketing, Inc. | 4 | $77 |
| Ardelyx, Inc. | 3 | $66 |
Products named: Fabhalta, Veltassa, RAYALDEE, TARPEYO, INSPIRE, JARDIANCE, ULTOMIRIS, JYNARQUE.
Industry payments across AL — which companies pay providers there.
